Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT02096471

MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1

This phase II open label study will evaluate adolescents (≥ 16 years of age) and adults with neurofibromatosis type-1 (NF1) and plexiform neurofibromas treated…

United States19 participantsStarted 2014-06

Treatment: PD-0325901